Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Erratum to "A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer" [Gynecologic Oncology 159 (2020) 827-838].
Gynecol Oncol. 2021 Oct;163(1):215. doi: 10.1016/j.ygyno.2021.07.018. Epub 2021 Jul 31.
Gynecol Oncol. 2021.
PMID: 34340816
No abstract available.
A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer.
Bantie L, Tadesse S, Likisa J, Yu M, Noll B, Heinemann G, Lokman NA, Ricciardelli C, Oehler MK, Beck A, Pradhan R, Milne R, Albrecht H, Wang S.
Bantie L, et al. Among authors: likisa j.
Gynecol Oncol. 2020 Dec;159(3):827-838. doi: 10.1016/j.ygyno.2020.09.012. Epub 2020 Sep 18.
Gynecol Oncol. 2020.
PMID: 32958271
Item in Clipboard
A Description of Mortality Associated with IPT plus ART Compared to ART Alone among HIV-Infected Individuals in Addis Ababa, Ethiopia: A Cohort Study.
Edessa D, Likisa J.
Edessa D, et al. Among authors: likisa j.
PLoS One. 2015 Sep 8;10(9):e0137492. doi: 10.1371/journal.pone.0137492. eCollection 2015.
PLoS One. 2015.
PMID: 26348618
Free PMC article.
Item in Clipboard
Cite
Cite